MedMarket Diligence's worldwide analysis of the markets for surgical sealants, glues, hemostasis, wound closure and anti-adhesion provides detail on growth segments of the market, both in the products/technologies and the geographic breakdown. Below is an excerpt from Report #S175.
The main medical markets in Latin America are Brazil and Mexico, followed by Argentina.
Brazil, despite its size (population 196 million), is not a lucrative medical market because of the wide economic disparity between the wealthy and poor segments of the population. The state-run Unified Health System (SUS) covers 75% of the population but only 42% of total health care expenditure is in the public sector. Private health care covers 17.5 million subscribers, less than 10% of the population. Thus conventional, low-cost closures (sutures, staples, tapes) dominate the market and more expensive novel closures (sealants and glues) have relatively modest market shares. The same is true of Argentina, which is still recovering from a severe economic depression in the 1990s. Mexico, the eighth biggest trading market in the world, operates a health care system under which 60%–70% of the population are covered by public insurance schemes. In terms of expenditure on medical products, Mexico occupies a position between that of developed and developing economies, and this is reflected in the shares of the wound closure market represented by premium-priced and commodity product groups.
Below is shown a graph of the major Latin American markets for these products. As is shown, sealants and glues have gained a significant share of these markets, yet additional penetration of the sutures and staples segment by sealants/glues, potentially to a large degree, may be gained with additional product development, conversion of caseload and aggressive marketing/promotional campaigns to physicians in these markets.
Source: MedMarket Diligence, LLC; Report #S175